SakshiJasraMD
Oncology • Burlington, VTHematologic Oncology
Assistant Professor, Department of Hematology and Oncology, University of Vermont
Dr. Jasra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Avenue
University of Vermont
Burlington, VT 05405
Summary
- Dr. Sakshi Jasra is an oncologist in Burlington, VT and is affiliated with University of Vermont Medical Center. She received her medical degree from St. George's University School of Medicine. She speaks multiple languages, including Hindi. She specializes in hematologic oncology and is experienced in acute myeloid leukemia, acute lymphoid leukemia, multiple myeloma, lymphoma, and myelodysplastic syndromes .
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2016 - 2019
University at BuffaloResidency, Internal Medicine, 2013 - 2016
St. George's University School of MedicineClass of 2013
University of WindsorBachelors of Science with Thesis, Biology, 2005 - 2009
Certifications & Licensure
VT State Medical License 2019 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 46 citationsAnthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.Sakshi Jasra, Jesus Anampa
Current Treatment Options in Oncology. 2018-05-11 - 3 citationsLenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B Donnellan, Jesus Berdeja
Clinical Cancer Research. 2023-01-04 - 18 citationsHigh burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster.Sakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, Kith Pradhan, David G Goldfarb
Nature Medicine. 2022-03-01
Lectures
- High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Causes and Predictors of Early Mortality in HIV-Positive and HIV-Negative Patients with Diffuse Large B-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Study Finds World Trade Center First Responders Have High Burden of Clonal HematopoiesisMay 17th, 2022
Professional Memberships
- Member
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
